Blood pressure effects of long-term stimulant use in disorders of hypersomnolence

Journal of Sleep Research

Volumn 7, Issue 3, 1998, Pages 209-215

  Wallin, Mitchell T ^a,c   Mahowald, Mark W ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Neurology Service   (United States)

Author keywords

CNS stimulants; Diastolic blood pressure; Hypertension; Narcolepsy; Systolic blood pressure

Indexed keywords

CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; METHYLPHENIDATE; PEMOLINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INFANT; MAJOR CLINICAL STUDY; MALE; NARCOLEPSY; PRIORITY JOURNAL; STATISTICAL MODEL; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE; CENTRAL NERVOUS SYSTEM STIMULANTS; DISORDERS OF EXCESSIVE SOMNOLENCE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NARCOLEPSY; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0031693116     PISSN: 09621105     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2869.1998.00110.x     Document Type: Article

References (40)

1. American Hospital Formulary Service. G. K. McEvoy (Bd.) American Society of Health-System Pharmacists, Belhesda, MD. 1995, 1550-1552, 1581-1587.
2. Berchtold, P., Jorgens, V., Finke, C. and Berger, M. Epidemiology of obesity and hypertension. Int. J. Obes., 1981, 5 (Suppl. 1): 1-7.
3. Bonisch, H. and Trendelenburg, U. The mechanism of action of indirectly acting sympathomimetic amines. In: U. Trendelenburg and N. Weiner (Eds) Handbook of Experimental Pharmacology, Catecholamines. Springer-Verlag, New York, 1988, 247-276.
4. Chiarello, R. J. and Cole, J. O. The use of psychostimulants in general psychiatry. A reconsideration. Arch. Gen. Psychiatry, 1987, 44: 286-295.
5. Coleman, R. M., Roffwarg, H. P., Kennedy, S. J., et al. Sleep wake disorders based on a polysomnographic diagnosis. A national cooperative study. JAMA, 1982, 247: 997-1003.
6. Daly, D. D. and Yoss, R. E. The treatment of narcolepsy with methyl phenylpiperidylacetate. A preliminary report. Staff Meet. Mayo Clin., 1956, 31: 620-625.
7. Davis, J. M., Kopin, I. J., Lemberger, L. and Axelrod, J. Effects of urinary pH on amphetamine metabolism. Ann. NY Acad. Sci., 1971, 179: 493-501.
8. Dement, W., Carskadon, M. and Ley, R. The prevalence of narcolepsy II. Sleep Res., 1973, 2: 147.
9. Dement, W., Zarcone, V., Varner, V., et al. The prevalence of narcolepsy. Sleep Res., 1972, 1: 148.
10. Glowinski, J. and Axelrod, J. Effects of drugs on the uptake, release and metabolism of 3H-norepinephrine in the rat brain. J. Pharmacol. Exp Ther., 1965, 149: 43-49.
11. Gordon, T. and Kannel, W. B. Obesity and cardiovascular disease. Framingham Study. Clin. Endocrinol. Metab., 1976, 5: 367-375.
12. Guilleminault, C. Amphetamines and narcolepsy: use of the Stanford database. Sleep, 1993, 16: 199-201.
13. Harrington, H., Heller, H., Dawson, D., Caplan, L. and Rumbaugh, C. Intracerebral hemorrhage and oral amphetamine. Arch. Neurol., 1983, 40: 503-507.
14. Hoffman, B. B. and Lefkowitz, R. J. Catecholamines and sympathomimetic drugs. In: Goodman and Gilman's: The Pharmacological Basis of Therapeutics, 8th edn. Pergamon Press, Philadelphia, 1990: 187-220.
15. Hsueh, W. A. and Buchanan, T. A. Obesity and hypertension. Endoc. Metab. Clin. North Am., 1994, 23: 405-427.
16. Hypertension Detection and Follow-up Program Cooperative Group. Blood pressure studies in 14 communities: a two-stage screen for hypertension. JAMA, 1977, 237: 2385-2391.
17. Iversen, L. L. Catecholamine uptake processes. Br. Med Bull., 1973, 29: 130-135.
18. Kaku, D. A. and Lowenstein, D. H. Emergence of recreational drug abuse as a major risk factor for stroke in young adults. Ann. Intern. Med., 1990, 113: 821-827.
19. Kannel, W. B. and Gordon, T. Evaluation of cardiovascular risk in the elderly. Framingham Study. Bull. NY Acad. Med., 1978, 54: 573-591.
20. Lin, T. Y., Hung, T. P., Chen, C. M., et al. A study of normal and elevated blood pressures in a Chinese urban population in Taiwan (Formosa). Clin. Sci., 1959, 18: .301-312.
21. Miall, W. E. and Lowell, H. G. Relation between change of blood pressure and age. Br. Med. J., 1967, 2: 660-664.
22. Mitler, M. M., Aldrich, M. S., Koob, G. F. and Zarcone, V. P. Narcolepsy and its treatment with stimulants. Sleep, 1994, 17: 352-371.
23. Miller, M. M., Hajdukovic, R. and Erman, M. K. Treatment of narcolepsy with methamphetamine. Sleep, 1993, 16: 306-317.
24. Modan, M., Halkin, H., Almog, S., et al. Hyperinsulinemia: a link between hypertension, obesity, and glucose intolerance. J. Clin. Invest., 1985, 75: 809-817.
25. Orzel, J. A. Acute myocardial infarction complicated by chronic amphetamine use. Arch. Int. Med., 1982, 142: 644.
26. Parkes, J. D. Amphetamines and other drugs in the treatment of daytime drowsiness and cataplexy. In: Sleep and its Disorders. London, WB Saunders, 1985: 45-482.
27. Parkes, J. D., Baraitser, M., Marsden, C. D. and Asselman, P. Natural history, symptoms and treatment of the narcoleptic syndrome. Acta Neurol. Scand., 1975, 52: 337-353.
28. Parkes, J. D. and Dahlitz, M. Amphetamine prescription. Sleep, 1993, 16: 201-203.
29. Parkes, J. D. and Fenton, G. W. Levo(-)amphetamine and dextro(+) amphetamine in the treatment of narcolepsy. J. Neurol. Neurosurg. Psychiatr., 1973, 36: 1076-1081.
30. Raiteri, M., Bertollini, A., Angelini, F. and Levi, G. d-Amphetamine as a release or reuptake inhibitor of biogenic amines in synaptosomes. Eur. J. Pharmacol., 1975, 34: 189-195.
31. Royall, R. M. Model robust confidence intervals using maximum likelihood estimators. Int. Statist. Rev., 1986, 54: 221-226.
32. Stamler, J., Stamler, R., Riedlinger, W. F., et al. Hypertension screening of 1 million Americans. Community Hypertension Evaluation Clinic (CHEC) Program, 1973 through 1975. JAMA, 1976, 235: 2299-2306.
33. Standards of Practice Committee of the American Sleep Disorders Association. Practice parameters for the use of stimulants in the treatment of narcolepsy. Sleep, 1994, 17: 348-351.
34. Svardsudd, K. and Tibblin, G. A longitudinal blood pressure study: change of blood pressure during 10 years in relation to initial values: the study of men born in 1913. J. Chronic Dis., 1980, 33: 627-636.
35. Szklo, M. Epidemiologic patterns of blood pressure in children. Epidemiol. Rev., 1979, 1: 143-165.
36. Taylor, D. and Ho, B. T. Comparison of Inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine. Res. Chem. Pathol. Pharmacol., 1978, 21: 67-75.
37. Ulrich, H. Narcolepsy and its treatment with benzedrine sulfate. NEJM., 1937, 217: 696-701.
38. Warneke, L. Psychostimulants in psychiatry. Can. J. Psychiatry, 1990, 35: 3-10.
39. Wilens, T. E. and Biederman, J. The stimulants. Psychiatr. Clin. North Am., 1992, 15: 191-222.
40. Zeger, S. L., Liang, K. Y. and Alber, P. S. Models for longitudinal data: a generalized estimating equation approach. Biometrics, 1988, 44: 1049-1060.